Industry Research Reports
Home > Reports > Chemical & Material > Global Gentiopicroside Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Gentiopicroside Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-26
Pages: 132 Pages
Report ld: 5283042
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Gentiopicroside market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Medicine accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Gentiopicroside leading manufacturers including Xian GAOYU Biotech, Hangzhou DayangChem, Herb Elements, Yi An Biological Technology, Abcam, Aktin Chemicals, Chengdu Herbpurify, etc., dominate supply; the top five capture approximately % of global revenue, with Xian GAOYU Biotech leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Gentiopicroside market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Xian GAOYU Biotech
- Hangzhou DayangChem
- Herb Elements
- Yi An Biological Technology
- Abcam
- Aktin Chemicals
- Chengdu Herbpurify
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pharmaceutical Grade
- Industrial Grade
Segment by Application
- Medicine
- Chemical Production
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Gentiopicroside study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Gentiopicroside: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gentiopicroside Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Market Segmentation by Application
1.3.1 Global Gentiopicroside Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Medicine
1.3.3 Chemical Production
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gentiopicroside Revenue Estimates and Forecasts 2020-2031
2.2 Global Gentiopicroside Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gentiopicroside Sales Estimates and Forecasts 2020-2031
2.4 Global Gentiopicroside Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Gentiopicroside Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Gentiopicroside Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Gentiopicroside Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Pharmaceutical Grade Market Size by Manufacturers
4.5.2 Industrial Grade Market Size by Manufacturers
4.6 Global Gentiopicroside Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Gentiopicroside Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Gentiopicroside Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Gentiopicroside Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Gentiopicroside Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Gentiopicroside Sales and Revenue by Type (2020-2031)
7.4 North America Gentiopicroside Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Gentiopicroside Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Gentiopicroside Sales and Revenue by Type (2020-2031)
8.4 Europe Gentiopicroside Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Gentiopicroside Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Gentiopicroside Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Gentiopicroside Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Gentiopicroside Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Gentiopicroside Sales and Revenue by Type (2020-2031)
10.4 Central and South America Gentiopicroside Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Gentiopicroside Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Gentiopicroside Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Gentiopicroside Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Gentiopicroside Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Xian GAOYU Biotech
12.1.1 Xian GAOYU Biotech Corporation Information
12.1.2 Xian GAOYU Biotech Business Overview
12.1.3 Xian GAOYU Biotech Gentiopicroside Product Models, Descriptions and Specifications
12.1.4 Xian GAOYU Biotech Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Xian GAOYU Biotech Gentiopicroside Sales by Product in 2024
12.1.6 Xian GAOYU Biotech Gentiopicroside Sales by Application in 2024
12.1.7 Xian GAOYU Biotech Gentiopicroside Sales by Geographic Area in 2024
12.1.8 Xian GAOYU Biotech Gentiopicroside SWOT Analysis
12.1.9 Xian GAOYU Biotech Recent Developments
12.2 Hangzhou DayangChem
12.2.1 Hangzhou DayangChem Corporation Information
12.2.2 Hangzhou DayangChem Business Overview
12.2.3 Hangzhou DayangChem Gentiopicroside Product Models, Descriptions and Specifications
12.2.4 Hangzhou DayangChem Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Hangzhou DayangChem Gentiopicroside Sales by Product in 2024
12.2.6 Hangzhou DayangChem Gentiopicroside Sales by Application in 2024
12.2.7 Hangzhou DayangChem Gentiopicroside Sales by Geographic Area in 2024
12.2.8 Hangzhou DayangChem Gentiopicroside SWOT Analysis
12.2.9 Hangzhou DayangChem Recent Developments
12.3 Herb Elements
12.3.1 Herb Elements Corporation Information
12.3.2 Herb Elements Business Overview
12.3.3 Herb Elements Gentiopicroside Product Models, Descriptions and Specifications
12.3.4 Herb Elements Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Herb Elements Gentiopicroside Sales by Product in 2024
12.3.6 Herb Elements Gentiopicroside Sales by Application in 2024
12.3.7 Herb Elements Gentiopicroside Sales by Geographic Area in 2024
12.3.8 Herb Elements Gentiopicroside SWOT Analysis
12.3.9 Herb Elements Recent Developments
12.4 Yi An Biological Technology
12.4.1 Yi An Biological Technology Corporation Information
12.4.2 Yi An Biological Technology Business Overview
12.4.3 Yi An Biological Technology Gentiopicroside Product Models, Descriptions and Specifications
12.4.4 Yi An Biological Technology Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Yi An Biological Technology Gentiopicroside Sales by Product in 2024
12.4.6 Yi An Biological Technology Gentiopicroside Sales by Application in 2024
12.4.7 Yi An Biological Technology Gentiopicroside Sales by Geographic Area in 2024
12.4.8 Yi An Biological Technology Gentiopicroside SWOT Analysis
12.4.9 Yi An Biological Technology Recent Developments
12.5 Abcam
12.5.1 Abcam Corporation Information
12.5.2 Abcam Business Overview
12.5.3 Abcam Gentiopicroside Product Models, Descriptions and Specifications
12.5.4 Abcam Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Abcam Gentiopicroside Sales by Product in 2024
12.5.6 Abcam Gentiopicroside Sales by Application in 2024
12.5.7 Abcam Gentiopicroside Sales by Geographic Area in 2024
12.5.8 Abcam Gentiopicroside SWOT Analysis
12.5.9 Abcam Recent Developments
12.6 Aktin Chemicals
12.6.1 Aktin Chemicals Corporation Information
12.6.2 Aktin Chemicals Business Overview
12.6.3 Aktin Chemicals Gentiopicroside Product Models, Descriptions and Specifications
12.6.4 Aktin Chemicals Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Aktin Chemicals Recent Developments
12.7 Chengdu Herbpurify
12.7.1 Chengdu Herbpurify Corporation Information
12.7.2 Chengdu Herbpurify Business Overview
12.7.3 Chengdu Herbpurify Gentiopicroside Product Models, Descriptions and Specifications
12.7.4 Chengdu Herbpurify Gentiopicroside Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Chengdu Herbpurify Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Gentiopicroside Industry Chain
13.2 Gentiopicroside Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Gentiopicroside Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Gentiopicroside Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Gentiopicroside Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Gentiopicroside Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Gentiopicroside Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Gentiopicroside Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Gentiopicroside Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Gentiopicroside Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Gentiopicroside Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Gentiopicroside Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Gentiopicroside Sales by Region (2020-2025) & (MT)
Table 8. Global Gentiopicroside Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Gentiopicroside Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Gentiopicroside Production by Region (2020-2025) & (MT)
Table 12. Global Gentiopicroside Production by Region (2026-2031) & (MT)
Table 13. Global Gentiopicroside Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Gentiopicroside Sales Share by Manufacturers (2020-2025)
Table 15. Global Gentiopicroside Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Gentiopicroside Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Gentiopicroside by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gentiopicroside as of 2024)
Table 19. Global Gentiopicroside Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Gentiopicroside Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)
Table 21. Key Manufacturers Gentiopicroside Manufacturing Base and Headquarters
Table 22. Global Gentiopicroside Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Gentiopicroside Sales by Type (2020-2025) & (MT)
Table 26. Global Gentiopicroside Sales by Type (2026-2031) & (MT)
Table 27. Global Gentiopicroside Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Gentiopicroside Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Gentiopicroside ASP by Type (2020-2031) & (USD/MT)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Gentiopicroside Sales by Application (2020-2025) & (MT)
Table 32. Global Gentiopicroside Sales by Application (2026-2031) & (MT)
Table 33. Gentiopicroside High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Gentiopicroside Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Gentiopicroside Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Gentiopicroside ASP by Application (2020-2031) & (USD/MT)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Gentiopicroside Growth Accelerators and Market Barriers
Table 40. North America Gentiopicroside Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Gentiopicroside Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Gentiopicroside Growth Accelerators and Market Barriers
Table 43. Europe Gentiopicroside Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Gentiopicroside Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Gentiopicroside Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Gentiopicroside Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Gentiopicroside Growth Accelerators and Market Barriers
Table 48. Southeast Asia Gentiopicroside Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Gentiopicroside Investment Opportunities and Key Challenges
Table 50. Central and South America Gentiopicroside Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Gentiopicroside Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Gentiopicroside Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Xian GAOYU Biotech Corporation Information
Table 54. Xian GAOYU Biotech Description and Major Businesses
Table 55. Xian GAOYU Biotech Product Models, Descriptions and Specifications
Table 56. Xian GAOYU Biotech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Xian GAOYU Biotech Sales Value Proportion by Product in 2024
Table 58. Xian GAOYU Biotech Sales Value Proportion by Application in 2024
Table 59. Xian GAOYU Biotech Sales Value Proportion by Geographic Area in 2024
Table 60. Xian GAOYU Biotech Gentiopicroside SWOT Analysis
Table 61. Xian GAOYU Biotech Recent Developments
Table 62. Hangzhou DayangChem Corporation Information
Table 63. Hangzhou DayangChem Description and Major Businesses
Table 64. Hangzhou DayangChem Product Models, Descriptions and Specifications
Table 65. Hangzhou DayangChem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 66. Hangzhou DayangChem Sales Value Proportion by Product in 2024
Table 67. Hangzhou DayangChem Sales Value Proportion by Application in 2024
Table 68. Hangzhou DayangChem Sales Value Proportion by Geographic Area in 2024
Table 69. Hangzhou DayangChem Gentiopicroside SWOT Analysis
Table 70. Hangzhou DayangChem Recent Developments
Table 71. Herb Elements Corporation Information
Table 72. Herb Elements Description and Major Businesses
Table 73. Herb Elements Product Models, Descriptions and Specifications
Table 74. Herb Elements Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Herb Elements Sales Value Proportion by Product in 2024
Table 76. Herb Elements Sales Value Proportion by Application in 2024
Table 77. Herb Elements Sales Value Proportion by Geographic Area in 2024
Table 78. Herb Elements Gentiopicroside SWOT Analysis
Table 79. Herb Elements Recent Developments
Table 80. Yi An Biological Technology Corporation Information
Table 81. Yi An Biological Technology Description and Major Businesses
Table 82. Yi An Biological Technology Product Models, Descriptions and Specifications
Table 83. Yi An Biological Technology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. Yi An Biological Technology Sales Value Proportion by Product in 2024
Table 85. Yi An Biological Technology Sales Value Proportion by Application in 2024
Table 86. Yi An Biological Technology Sales Value Proportion by Geographic Area in 2024
Table 87. Yi An Biological Technology Gentiopicroside SWOT Analysis
Table 88. Yi An Biological Technology Recent Developments
Table 89. Abcam Corporation Information
Table 90. Abcam Description and Major Businesses
Table 91. Abcam Product Models, Descriptions and Specifications
Table 92. Abcam Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. Abcam Sales Value Proportion by Product in 2024
Table 94. Abcam Sales Value Proportion by Application in 2024
Table 95. Abcam Sales Value Proportion by Geographic Area in 2024
Table 96. Abcam Gentiopicroside SWOT Analysis
Table 97. Abcam Recent Developments
Table 98. Aktin Chemicals Corporation Information
Table 99. Aktin Chemicals Description and Major Businesses
Table 100. Aktin Chemicals Product Models, Descriptions and Specifications
Table 101. Aktin Chemicals Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Aktin Chemicals Recent Developments
Table 103. Chengdu Herbpurify Corporation Information
Table 104. Chengdu Herbpurify Description and Major Businesses
Table 105. Chengdu Herbpurify Product Models, Descriptions and Specifications
Table 106. Chengdu Herbpurify Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Chengdu Herbpurify Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Gentiopicroside Product Picture
Figure 2. Global Gentiopicroside Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Gentiopicroside Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Medicine
Figure 7. Chemical Production
Figure 8. Others
Figure 9. Gentiopicroside Report Years Considered
Figure 10. Global Gentiopicroside Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 12. Global Gentiopicroside Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Gentiopicroside Revenue Market Share by Region (2020-2031)
Figure 14. Global Gentiopicroside Sales (2020-2031) & (MT)
Figure 15. Global Gentiopicroside Sales (CAGR) by Region (2020-2031) (MT)
Figure 16. Global Gentiopicroside Sales Market Share by Region (2020-2031)
Figure 17. Global Gentiopicroside Capacity, Production and Utilization (2020-2031) & (MT)
Figure 18. Global Gentiopicroside Production Trend by Region (2020-2031) (MT)
Figure 19. Global Gentiopicroside Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Gentiopicroside Production Growth Rate in North America (2020-2031) & (MT)
Figure 22. Gentiopicroside Production Growth Rate in Europe (2020-2031) & (MT)
Figure 23. Gentiopicroside Production Growth Rate in China (2020-2031) & (MT)
Figure 24. Gentiopicroside Production Growth Rate in Japan (2020-2031) & (MT)
Figure 25. Top 5 and Top 10 Manufacturers Gentiopicroside Sales Volume Market Share in 2024
Figure 26. Global Gentiopicroside Revenue Market Share Ranking (2024)
Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 28. Pharmaceutical Grade Revenue Market Share by Manufacturer in 2024
Figure 29. Industrial Grade Revenue Market Share by Manufacturer in 2024
Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 32. Global Gentiopicroside Sales Market Share by Type (2020-2031)
Figure 33. Global Gentiopicroside Revenue Market Share by Type (2020-2031)
Figure 34. Global Gentiopicroside Sales Market Share by Application (2020-2031)
Figure 35. Global Gentiopicroside Revenue Market Share by Application (2020-2031)
Figure 36. North America Gentiopicroside Sales YoY (2020-2031) & (MT)
Figure 37. North America Gentiopicroside Revenue YoY (2020-2031) & (US$ Million)
Figure 38. North America Top 5 Manufacturers Gentiopicroside Sales Revenue (US$ Million) in 2024
Figure 39. North America Gentiopicroside Sales Volume (MT) by Type (2020- 2031)
Figure 40. North America Gentiopicroside Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 41. North America Gentiopicroside Sales Volume (MT) by Application (2020-2031)
Figure 42. North America Gentiopicroside Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. US Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 44. Canada Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 45. Mexico Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 46. Europe Gentiopicroside Sales YoY (2020-2031) & (MT)
Figure 47. Europe Gentiopicroside Revenue YoY (2020-2031) & (US$ Million)
Figure 48. Europe Top 5 Manufacturers Gentiopicroside Sales Revenue (US$ Million) in 2024
Figure 49. Europe Gentiopicroside Sales Volume (MT) by Type (2020-2031)
Figure 50. Europe Gentiopicroside Sales Revenue (US$ Million) by Type (2020-2031)
Figure 51. Europe Gentiopicroside Sales Volume (MT) by Application (2020-2031)
Figure 52. Europe Gentiopicroside Sales Revenue (US$ Million) by Application (2020-2031)
Figure 53. Germany Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 54. France Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 55. U.K. Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 56. Italy Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 57. Russia Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 58. Asia-Pacific Gentiopicroside Sales YoY (2020-2031) & (MT)
Figure 59. Asia-Pacific Gentiopicroside Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Top 8 Manufacturers Gentiopicroside Sales Revenue (US$ Million) in 2024
Figure 61. Asia-Pacific Gentiopicroside Sales Volume (MT) by Type (2020- 2031)
Figure 62. Asia-Pacific Gentiopicroside Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 63. Asia-Pacific Gentiopicroside Sales Volume (MT) by Application (2020-2031)
Figure 64. Asia-Pacific Gentiopicroside Sales Revenue (US$ Million) by Application (2020-2031)
Figure 65. Indonesia Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 66. Japan Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 67. South Korea Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 68. China Taiwan Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 69. India Gentiopicroside Revenue (2020-2031) & (US$ Million)
Figure 70. Central and South America Gentiopicroside Sales YoY (2020-2031) & (MT)
Figure 71. Central and South America Gentiopicroside Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Central and South America Top 5 Manufacturers Gentiopicroside Sales Revenue (US$ Million) in 2024
Figure 73. Central and South America Gentiopicroside Sales Volume (MT) by Type (2021-2031)
Figure 74. Central and South America Gentiopicroside Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Central and South America Gentiopicroside Sales Volume (MT) by Application (2020-2031)
Figure 76. Central and South America Gentiopicroside Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. Brazil Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 78. Argentina Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 79. Middle East, and Africa Gentiopicroside Sales YoY (2020-2031) & (MT)
Figure 80. Middle East and Africa Gentiopicroside Revenue YoY (2020-2031) & (US$ Million)
Figure 81. Middle East and Africa Top 5 Manufacturers Gentiopicroside Sales Revenue (US$ Million) in 2024
Figure 82. Middle East and Africa Gentiopicroside Sales Volume (MT) by Type (2021-2031)
Figure 83. South America Gentiopicroside Sales Revenue (US$ Million) by Type (2020-2031)
Figure 84. Middle East and Africa Gentiopicroside Sales Volume (MT) by Application (2020-2031)
Figure 85. Middle East and Africa Gentiopicroside Sales Revenue (US$ Million) by Application (2020-2031)
Figure 86. GCC Countries Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 87. Turkey Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 88. Egypt Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 89. South Africa Gentiopicroside Revenue (2020-2025) & (US$ Million)
Figure 90. Gentiopicroside Industry Chain Mapping
Figure 91. Regional Gentiopicroside Manufacturing Base Distribution (%)
Figure 92. Gentiopicroside Production Process
Figure 93. Regional Gentiopicroside Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Gentiopicroside market?
The top companies in the global Gentiopicroside market are Xian GAOYU Biotech、Hangzhou DayangChem、Herb Elements.
Related Reports
Gentiopicroside- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gentiopicroside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 127
USD 3950.00
(Single User License)
Global Gentiopicroside Market Research Report 2026
The global Gentiopicroside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 126
USD 2900.00
(Single User License)
Global Gentiopicroside Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gentiopicroside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 77
USD 4250.00
(Single User License)
Gentiopicroside- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gentiopicroside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 97
USD 3950.00
(Single User License)
Global Gentiopicroside Market Research Report 2025
The global market for Gentiopicroside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 92
USD 2900.00
(Single User License)
Gentiopicroside - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gentiopicroside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 97
USD 3950.00
(Single User License)
Global Gentiopicroside Market Research Report 2024
The global Gentiopicroside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 92
USD 2900.00
(Single User License)
Gentiopicroside- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Gentiopicroside was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 127
USD 3950.00 (Single User License)Global Gentiopicroside Market Research Report 2026
The global Gentiopicroside market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 126
USD 2900.00 (Single User License)Global Gentiopicroside Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Gentiopicroside market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 77
USD 4250.00 (Single User License)Gentiopicroside- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Gentiopicroside was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 97
USD 3950.00 (Single User License)Global Gentiopicroside Market Research Report 2025
The global market for Gentiopicroside was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 92
USD 2900.00 (Single User License)Gentiopicroside - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Gentiopicroside was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 97
USD 3950.00 (Single User License)Global Gentiopicroside Market Research Report 2024
The global Gentiopicroside market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 92
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now